Unlocking Biomanufacturing Flexibility for Rapid Scaling and Supply Resilience in Upcoming Webinar Join an informative webinar on biomanufacturing strategies that expedite development timelines, minimize supply risks, and enhance product resilience.

Unlocking Biomanufacturing Flexibility for Rapid Scaling and Supply Resilience in Upcoming Webinar #Canada #Toronto #Biomanufacturing #CDMO_Services #Xtalks

Scinai Immunotherapeutics Shares Strong Nine-Month 2025 Performance as CDMO Services Thrive Scinai Immunotherapeutics has reported impressive financial results for the first nine months of 2025, showcasing growth in CDMO services and advancing its innovative NanoAbs pipeline.

Scinai Immunotherapeutics Shares Strong Nine-Month 2025 Performance as CDMO Services Thrive #Scinai_Immunotherapeutics #Israel #Jerusalem #CDMO_Services #NanoAbs

Elevaris Unveils New CDMO Services and Needle Range at COMPAMED 2025 Elevaris Medical Devices is set to introduce its contract development and manufacturing services along with an extensive needle portfolio at COMPAMED 2025 in Düsseldorf, Germany.

Elevaris Unveils New CDMO Services and Needle Range at COMPAMED 2025 #Germany #Medical_Devices #Düsseldorf #CDMO_Services #Elevaris

Elevaris Medical Devices Launches CDMO Services and Procedural Needles in EMEA Elevaris Medical Devices makes its debut at COMPAMED, showcasing its CDMO services and a range of procedural needles in the EMEA region.

Elevaris Medical Devices Launches CDMO Services and Procedural Needles in EMEA #USA #Boston #CDMO_Services #Elevaris_Medical #Procedural_Needles

Elevaris Expands its Reach with CDMO Services and Needle Portfolio in EMEA Elevaris Medical Devices has introduced its CDMO services and specialized procedural needles in the EMEA region. Discover their innovative capabilities at COMPAMED.

Elevaris Expands its Reach with CDMO Services and Needle Portfolio in EMEA #None #Düsseldorf #CDMO_Services #Elevaris_Medical #Procedural_Needles

Scinai Immunotherapeutics Sees Financial Growth in 2025 with Enhanced CDMO Revenue Scinai Immunotherapeutics reports significant financial growth in H1 2025, with CDMO revenue increasing and a strengthened balance sheet.

Scinai Immunotherapeutics Sees Financial Growth in 2025 with Enhanced CDMO Revenue #None #Scinai_Immunotherapeutics #biopharmaceuticals #CDMO_Services

MedEdge Innovations Launches Advanced ePTFE Platform and CDMO Services for Medical Devices MedEdge Innovations introduces a new ePTFE platform along with customized CDMO services designed for medical implant applications, ensuring high performance and reliability for device manufacturers.

MedEdge Innovations Launches Advanced ePTFE Platform and CDMO Services for Medical Devices #China #Suzhou #CDMO_Services #MedEdge_Innovations #ePTFE

Scinai Unveils New Funding and Promotes CDMO Expansion During Upcoming BIO International Convention 2025 Scinai Immunotherapeutics announces exciting funding achievements and growth in its CDMO services, setting the stage for the BIO International Convention 2025.

Scinai Unveils New Funding and Promotes CDMO Expansion During Upcoming BIO International Convention 2025 #Scinai_Immunotherapeutics #Israel #Jerusalem #CDMO_Services #BIO_Convention_2025

Scinai Immunotherapeutics to Present Cutting-Edge Innovations at BIO-Europe Spring 2025 Scinai Immunotherapeutics will showcase its advanced inflammation and immunology pipeline during BIO-Europe Spring 2025 in Milan, enhancing visibility and investor engagement.

Scinai Immunotherapeutics to Present Cutting-Edge Innovations at BIO-Europe Spring 2025 #Scinai_Immunotherapeutics #Israel #Jerusalem #CDMO_Services #NanoAbs

Scinai Immunotherapeutics Prepares for Major US Conferences to Connect with Industry Leaders Scinai Immunotherapeutics is set to engage with investors and pharma leaders at major upcoming US conferences. Key executives will seek strategic partnerships and showcase their innovative nanoAbs.

Scinai Immunotherapeutics Prepares for Major US Conferences to Connect with Industry Leaders #USA #Scinai_Immunotherapeutics #CDMO_Services #NanoAbs #Miami,_San_Francisco